Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Osteoporosis, Postmenopausal"" wg kryterium: Temat


Tytuł:
Expression profile analysis of lncRNA in bone marrow mesenchymal stem cells exosomes of postmenopausal osteoporosis patients through microarray and bioinformatics analyses.
Autorzy:
Wang J; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Fu M; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
He S; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Cai P; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Xiang X; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Fang L; Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2022 Aug; Vol. 236, pp. 153985. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Exosomes*/genetics
Exosomes*/metabolism
Mesenchymal Stem Cells*/metabolism
Osteoporosis, Postmenopausal*/genetics
Osteoporosis, Postmenopausal*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Bone Marrow Cells/metabolism ; Computational Biology ; Female ; Humans ; Phosphatidylinositol 3-Kinases/metabolism
Czasopismo naukowe
Tytuł:
Effects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf-1 in postmenopausal osteoporosis with and without periodontitis.
Autorzy:
Ozden FO; Department of Periodontology, Faculty of Dentistry, Ondokuz Mayıs University, Samsun, Turkey.
Demir E; Department of Periodontology, Faculty of Dentistry, Bezmialem Vakıf University, İstanbul, Turkey.
Lutfioglu M; Department of Periodontology, Faculty of Dentistry, Ondokuz Mayıs University, Samsun, Turkey.
Acarel EE; Department of Periodontology, Faculty of Dentistry, Ondokuz Mayıs University, Samsun, Turkey.
Bilgici B; Department of Biochemistry, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Atmaca A; Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Pokaż więcej
Źródło:
Journal of periodontal research [J Periodontal Res] 2022 Aug; Vol. 57 (4), pp. 849-858. Date of Electronic Publication: 2022 Jun 04.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/metabolism
Periodontitis*/metabolism
Diphosphonates/metabolism ; Diphosphonates/therapeutic use ; Female ; Gingiva ; Gingival Crevicular Fluid/metabolism ; Humans
Czasopismo naukowe
Tytuł:
Osteoporosis among Postmenopausal Women in Jordan: A National Cross-Sectional Study.
Autorzy:
Saadeh R; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Jumaa D; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Elsalem L; Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Batieha A; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Jaddou H; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Khader Y; Department of Public Health and Community Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
El-Khateeb M; The National Center (Institute) for Diabetes, Endocrinology and Genetics, University of Jordan, Amman 11942, Jordan.
Ajlouni K; The National Center (Institute) for Diabetes, Endocrinology and Genetics, University of Jordan, Amman 11942, Jordan.
Allouh MZ; Department of Anatomy, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.; Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
Pokaż więcej
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Jul 20; Vol. 19 (14). Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/epidemiology
Osteoporosis, Postmenopausal*/epidemiology
Osteoporosis, Postmenopausal*/prevention & control
Aged ; Bone Density ; Calcium ; Calcium, Dietary ; Cross-Sectional Studies ; Female ; Humans ; Jordan/epidemiology ; Male ; Postmenopause ; Vitamin D
Czasopismo naukowe
Tytuł:
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Autorzy:
Chiba K; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan. Electronic address: .
Okazaki N; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Kurogi A; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Watanabe T; Watanabe Orthopedic Clinic, Nagasaki University Hospital, Japan.
Mori A; Nagasaki Yurino Hospital, Nagasaki University Hospital, Japan.
Suzuki N; Nagasaki Yurino Hospital, Nagasaki University Hospital, Japan.
Adachi K; Nagasaki Yurino Hospital, Nagasaki University Hospital, Japan.
Era M; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Yokota K; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Inoue T; Juko Memorial Nagasaki Hospital, Nagasaki University Hospital, Japan.
Yabe Y; Juko Memorial Nagasaki Hospital, Nagasaki University Hospital, Japan.
Furukawa K; Furukawa Orthopedic Clinic, Nagasaki University Hospital, Japan.
Kondo C; Kondo Orthopedic Clinic, Nagasaki University Hospital, Japan.
Tsuda K; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Ota S; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Isobe Y; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Miyazaki S; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Morimoto S; Clinical Research Center, Nagasaki University Hospital, Japan.
Sato S; Clinical Research Center, Nagasaki University Hospital, Japan.
Nakashima S; Clinical Research Center, Nagasaki University Hospital, Japan.
Tashiro S; Clinical Research Center, Nagasaki University Hospital, Japan.
Yonekura A; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Tomita M; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Osaki M; Department of Orthopedic Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University Hospital, Japan.
Pokaż więcej
Źródło:
Bone [Bone] 2022 Jul; Vol. 160, pp. 116416. Date of Electronic Publication: 2022 Apr 06.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Osteoporosis, Postmenopausal*/diagnostic imaging
Osteoporosis, Postmenopausal*/drug therapy
Teriparatide*/pharmacology
Teriparatide*/therapeutic use
Absorptiometry, Photon ; Bone Density ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Female ; Humans ; Radius/diagnostic imaging ; Tibia
Czasopismo naukowe
Tytuł:
Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women.
Autorzy:
Menale C; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Via Pansini 5, 80131 Napoli, Italy.
Tabacco G; Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.; Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Naciu AM; Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.; Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Schiavone ML; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.
Cannata F; Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Morenghi E; Biostatistics Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.
Sobacchi C; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.; CNR-IRGB, Milan Unit, Via Fantoli 16/15, 20138 Milan, Italy.
Palermo A; Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.; Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jun 19; Vol. 27 (12). Date of Electronic Publication: 2022 Jun 19.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/genetics
Animals ; Biomarkers ; Bone Density ; Cross-Sectional Studies ; Denosumab/metabolism ; Denosumab/pharmacology ; Denosumab/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Female ; Humans ; Kelch-Like ECH-Associated Protein 1/metabolism ; Mice ; NF-E2-Related Factor 2/metabolism ; Postmenopause ; Prospective Studies
Czasopismo naukowe
Tytuł:
Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
Autorzy:
Dong Q; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.; Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, China.; Clinical Research Center for Metabolic Disease, Gansu Provincial Hospital, Lanzhou, China.
Han Z; Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, China.; Clinical Research Center for Metabolic Disease, Gansu Provincial Hospital, Lanzhou, China.
Tian L; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.; Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, China.; Clinical Research Center for Metabolic Disease, Gansu Provincial Hospital, Lanzhou, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jun 09; Vol. 13, pp. 899503. Date of Electronic Publication: 2022 Jun 09 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Exosomes*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Osteoporosis, Postmenopausal*/blood
Osteoporosis, Postmenopausal*/genetics
RNA, Circular*/genetics
RNA, Messenger*/genetics
RNA, Messenger*/metabolism
Transcription Factors*/blood
Transcription Factors*/genetics
Biomarkers/metabolism ; Computational Biology/methods ; Female ; Gene Expression Profiling/methods ; Gene Regulatory Networks ; Humans
Czasopismo naukowe
Tytuł:
Sociodemographic factors affecting the disease acceptance in the group of women with postmenopausal osteoporosis.
Autorzy:
Górczewska B; Medical University of Lodz, Łódź, Poland (Department of Pediatrics, Neonatal Pathology and Bone Metabolism Diseases).
Jakubowska-Pietkiewicz E; Medical University of Lodz, Łódź, Poland (Department of Pediatrics, Neonatal Pathology and Bone Metabolism Diseases).
Pokaż więcej
Źródło:
International journal of occupational medicine and environmental health [Int J Occup Med Environ Health] 2022 Jun 08; Vol. 35 (3), pp. 273-283. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*
Osteoporosis, Postmenopausal*/diagnosis
Osteoporosis, Postmenopausal*/psychology
Aged ; Educational Status ; Female ; Humans ; Sociodemographic Factors ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea.
Autorzy:
Rhee Y; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Chang DG; Department of Orthopedic Surgery, Inje University Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea.
Ha J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim S; Amgen Korea Ltd., Seoul, Korea.
Lee Y; Amgen Korea Ltd., Seoul, Korea.
Jo E; Amgen Korea Ltd., Seoul, Korea.
Koh JM; Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2022 Jun; Vol. 37 (3), pp. 497-505. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Observational Study; Randomized Controlled Trial
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/chemically induced
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Aged ; Denosumab/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł:
Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axis.
Autorzy:
Sun P; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China; Longhua Hospital, Institute of Spine, Shanghai University of Traditional Chinese Medicine, Key Laboratory, Ministry of Education of China, Shanghai 200032, China.
Zhang C; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Huang Y; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Yang J; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China; The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Zhou F; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Zeng J; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Lin Y; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China; College of Acupuncture and Moxibustion, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jun; Vol. 150, pp. 112975. Date of Electronic Publication: 2022 Apr 19.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/prevention & control
Animals ; Cytokines/pharmacology ; Fatty Acids, Volatile/pharmacology ; Female ; Humans ; Rats ; Rats, Sprague-Dawley ; T-Lymphocytes, Regulatory ; Th17 Cells
Czasopismo naukowe
Tytuł:
Osteoporosis and periodontal diseases - An update on their association and mechanistic links.
Autorzy:
Yu B; Division of Regenerative and Constitutive Sciences, School of Dentistry, University of California at Los Angeles, Los Angeles, California, USA.
Wang CY; Division of Oral Biology and Medicine, School of Dentistry, University of California at Los Angeles, Los Angeles, California, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, Broad Stem Cell Research Center and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Periodontology 2000 [Periodontol 2000] 2022 Jun; Vol. 89 (1), pp. 99-113. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alveolar Bone Loss*/complications
Osteoporosis*/complications
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Periodontal Diseases*/complications
Periodontal Diseases*/therapy
Periodontitis*/complications
Periodontitis*/therapy
Aged ; Bone Density/physiology ; Female ; Humans ; Inflammation/complications
Czasopismo naukowe
Tytuł:
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types.
Autorzy:
Jörg DJ; Biomedical Modeling and Simulation Group, Global Research and Development, Fresenius Medical Care Germany, Bad Homburg, Germany.
Fuertinger DH; Biomedical Modeling and Simulation Group, Global Research and Development, Fresenius Medical Care Germany, Bad Homburg, Germany.
Cherif A; Renal Research Institute, New York, United States.
Bushinsky DA; Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, United States.
Mermelstein A; Renal Research Institute, New York, United States.
Raimann JG; Renal Research Institute, New York, United States.
Kotanko P; Renal Research Institute, New York, United States.; Icahn School of Medicine at Mount Sinai, New York, United States.
Pokaż więcej
Źródło:
ELife [Elife] 2022 Aug 09; Vol. 11. Date of Electronic Publication: 2022 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Diphosphonates/therapeutic use ; Drug Combinations ; Female ; Humans
Czasopismo naukowe
Tytuł:
Romosozumab and Renal Function.
Autorzy:
Watts NB; Mercy Health Osteoporosis and Bone Health Services, Cincinnati, OH, USA.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Aug; Vol. 37 (8), pp. 1435-1436. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:
Editorial
MeSH Terms:
Bone Density Conservation Agents*
Osteoporosis, Postmenopausal*
Antibodies, Monoclonal/pharmacology ; Bone Density ; Female ; Humans ; Kidney/physiology
Opinia redakcyjna
Tytuł:
The association between common serum adipokines levels and postmenopausal osteoporosis: A meta-analysis.
Autorzy:
Shu L; Department of Emergency Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Fu Y; Department of Emergency Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Sun H; Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Aug; Vol. 26 (15), pp. 4333-4342. Date of Electronic Publication: 2022 Jul 05.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Leptin*
Osteoporosis, Postmenopausal*
Adipokines ; Adiponectin ; Bone Density ; Female ; Humans
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Autorzy:
Miller PD; Colorado Center for Bone Health, Lakewood, CO, USA.
Adachi JD; St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, Canada.
Albergaria BH; Federal University of Espirito Santo, Espirito Santo Research and Osteoporosis Center, Vitória, Brazil.
Cheung AM; Department of Medicine, University Health Network, University of Toronto, Toronto, Canada.
Chines AA; Amgen Inc., Thousand Oaks, CA, USA.
Gielen E; Gerontology and Geriatrics, Department of Public Health and Primary Care, KU Leuven & Center for Metabolic Bone Diseases, UZ Leuven, Leuven, Belgium.
Langdahl BL; Aarhus University Hospital, Aarhus, Denmark.
Miyauchi A; Miyauchi Medical Center, Osaka, Japan.
Oates M; Amgen Inc., Thousand Oaks, CA, USA.
Reid IR; University of Auckland, Auckland, New Zealand.
Santiago NR; Amgen Inc., Thousand Oaks, CA, USA.
Vanderkelen M; UCB S.A, Brussels, Belgium.
Wang Z; Amgen Inc., Thousand Oaks, CA, USA.
Yu Z; Amgen Inc., Thousand Oaks, CA, USA.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Aug; Vol. 37 (8), pp. 1437-1445. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Fractures, Bone*/epidemiology
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/drug therapy
Alendronate/pharmacology ; Antibodies, Monoclonal ; Bone Density ; Female ; Femur Neck ; Humans ; Postmenopause
Czasopismo naukowe
Tytuł:
Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics.
Autorzy:
Li B; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Wang Y; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Gong S; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, China.
Yao W; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, China.
Gao H; Division of Pharmacology Laboratory, National Institutes for Food and Drug Control, Beijing, China.
Liu M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, China. Electronic address: .
Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, China; Liaoning Medical Diagnosis and Treatment Center, Shenyang, China. Electronic address: minjie_.
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2022 Jul 20; Vol. 102, pp. 154198. Date of Electronic Publication: 2022 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/metabolism
Osteoporosis, Postmenopausal*/drug therapy
Animals ; Fatty Acids, Unsaturated ; Female ; Humans ; Isoflavones ; Lipid Metabolism ; Metabolomics ; Osteogenesis ; Ovariectomy/adverse effects ; PPAR gamma/metabolism ; Phospholipids ; Rats
Czasopismo naukowe
Tytuł:
Factors influencing self-care in postmenopausal women with osteoporosis: The Guardian Angel® multicentric longitudinal study.
Autorzy:
Cittadini N; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
Basilici Zannetti E; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy. Electronic address: .
Iovino P; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy; School of Nursing, Midwifery and Paramedicine Faculty of Health Science, Australian Catholic University, Melbourne, Australia.
De Maria M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
D'Angelo D; National Center for Clinical Excellence, Healthcare Quality and Safety, Istituto Superiore di Sanità, Rome, Italy.
Pennini A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
Vellone E; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
Alvaro R; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
Pokaż więcej
Źródło:
Maturitas [Maturitas] 2022 Jul; Vol. 161, pp. 7-11. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Fractures, Bone*/epidemiology
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Aged ; Bone Density ; Female ; Humans ; Longitudinal Studies ; Postmenopause ; Risk Factors ; Self Care
Czasopismo naukowe
Tytuł:
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
Autorzy:
Pérez-Castrillón JL; Internal Medicine Department, Hospital Universitario Río Hortega, Valladolid, Spain.; School of Medicine, Universidad de Valladolid, Valladolid, Spain.
Dueñas-Laita A; School of Medicine, Universidad de Valladolid, Valladolid, Spain.; Clinical Toxicology Unit, Hospital Universitario Río Hortega, Valladolid, Spain.
Gómez-Alonso C; Bone Metabolism Unit, Hospital Universitario Central de Asturias-Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Bouillon R; Department of Chronic Diseases and Metabolism, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.
Jódar E; Department of Endocrinology & Clinical Nutrition, Hospital Universitario Universitario Quironsalud Madrid, Madrid, Spain.; School of Health Sciences, Universidad Europea, Madrid, Spain.
Brandi ML; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio', Università degli Studi di Firenze, Florence, Italy.
González-Macías J; Instituto de Investigación Marqués de Valdecilla - Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.; School of Medicine, Universidad de Cantabria, Santander, Spain.
Quesada-Gómez JM; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.; Hospital Universitario Reina Sofía, Córdoba, Spain.
Olmos Martínez JM; School of Medicine, Universidad de Cantabria, Santander, Spain.; Internal Medicine Department, Hospital Universitario Marqués de Valdecilla-Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.
Galarraga B; Rheumatology Department, Hospital Quirónsalud Bizkaia, Erandio, Spain.
Del Pino-Montes J; School of Medicine, Universidad de Salamanca, Salamanca, Spain.
Alhambra Expósito MR; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.; Endocrinology and Nutrition Unit, Hospital Universitario Reina Sofía, Córdoba, Spain.
Cereto Castro F; Internal Medicine Department, Hospital Quirón Barcelona, Barcelona, Spain.
Gallego López L; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Hernández-Herrero G; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Fernández-Hernando N; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Arranz-Gutiérrez P; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Chinchilla SP; R&D and Innovation Department, Faes Farma, Leioa, Spain.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jul; Vol. 37 (7), pp. 1413-1415. Date of Electronic Publication: 2022 Jun 10.
Typ publikacji:
Letter
MeSH Terms:
Calcifediol*
Osteoporosis, Postmenopausal*
Cholecalciferol ; Dietary Supplements ; Female ; Humans ; Postmenopause ; Vitamin D
Opinia redakcyjna
Tytuł:
The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial.
Autorzy:
Benjawan S; Department of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok 10400, Thailand.
Nimitphong H; Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama VI Road, Rajathevi, Bangkok 10400, Thailand.
Tragulpiankit P; Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Sri-Ayuthaya Road, Rajathevi, Bangkok 10400, Thailand.
Musigavong O; Chao Phraya Abhaibhubejhr Hospital, Prachin Anuson Road, Tha Ngam, Mueang Prachinburi, Prachinburi 25000, Thailand.
Prathanturarug S; Department of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok 10400, Thailand.
Pathomwichaiwat T; Department of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok 10400, Thailand. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2022 Jul; Vol. 101, pp. 154115. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bone Diseases, Metabolic*/drug therapy
Cissus*
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Biomarkers ; Bone Density ; Collagen Type I ; Double-Blind Method ; Female ; Humans ; Postmenopause
Czasopismo naukowe
Tytuł:
Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women.
Autorzy:
Sosa-Henríquez M; University of Las Palmas de Gran Canaria, Investigation Group on Osteoporosis and Bone and Mineral Diseases, Las Palmas de Gran Canaria, Spain.; Bone Metabolic Unit, Hospital University Insular, Las Palmas de Gran Canaria, Spain.
de Tejada-Romero MAJG; Department of Medicine, University of Seville, Seville, Spain.
Cancelo-Hidalgo MAJ; University Hospital of Guadalajara, Alcalá University, Madrid, Spain.
Díaz-Guerra GM; University Hospital 12 de Octubre. Madrid, University Complutense, Madrid, Spain.
Etxebarría Foronda Í; Department of Orthopaedic, Alto Deba Hospital, Mondragon, Spain.
Tarazona-Santabalbina FJ; Geriatric Service, University Hospital La Ribera, Alzira, Spain.
Torregrosa-Suau Ó; Bone Metabolic Unit. Service of Internal Medicine, University General Hospital, Elche, Spain.
Valdés-Llorca C; Health Center of Fuencarral. SERMAS, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jul; Vol. 37 (7), pp. 1411-1412. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Letter
MeSH Terms:
Osteoporosis, Postmenopausal*
Vitamin D Deficiency*/drug therapy
Calcifediol ; Cholecalciferol ; Dietary Supplements ; Female ; Humans ; Postmenopause ; Vitamin D
Opinia redakcyjna
Tytuł:
Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial.
Autorzy:
Jamshidi A; Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Vojdanian M; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Soroush M; Rheumatology Department, AJA University of Medical Sciences, Tehran, Iran.
Akbarian M; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Aghaei M; Golestan Rheumatology Research Center (GRRC), Golestan University of Medical Sciences, Gorgan, Iran.
Hajiabbasi A; Department of Rheumatology, Guilan Rheumatology Research Center, School of Medicine, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Mirfeizi Z; Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Khabbazi A; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Alishiri G; Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Haghighi A; Rheumatology Department, Iran University of Medical Sciences, Tehran, Iran.
Salimzadeh A; Rheumatology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Karimzadeh H; Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Shirani F; Department of Rheumatology, Iran University of Medical Sciences, Tehran, Iran.
Fard MRH; Rheumatology Ward, Internal Medicine Department, Mashhad University of Medical Sciences, Mashhad, Iran.
Nazarinia M; Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Soroosh S; Rheumatology Department, AJA University of Medical Sciences, Tehran, Iran.
Anjidani N; Medical Department, Orchid Pharmed Company, Tehran, Iran.
Gharibdoost F; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2022 Jun 30; Vol. 24 (1), pp. 161. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Bone Density Conservation Agents*/adverse effects
Osteoporosis*
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Denosumab/adverse effects ; Double-Blind Method ; Female ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz